BioSpace News Archive

Drug Development

Boehringer Ingelheim Corporation Release: Phase III Results: Tiotropium* Respimat® Effective in Symptomatic Asthma Patients Despite at Least ICS†/LABA‡ Independent of Their Age, Allergic Status, Smoking Status and Bronchodilator Response

May 21, 2013
·
1 min read
BioCapital

Biotechnology Industry Organization (BIO) Welcomes EPA Proposed Rule on New RFS2 Pathways

May 21, 2013
·
1 min read
Drug Development

Verona Pharma Release: Further Clinical Data Highlighting the Significant Bronchodilator Activity of Novel Dual PDE3/4 Inhibitor RPL554 Presented at American Thoracic Society International Conference

May 21, 2013
·
5 min read
Elbit Imaging Ltd. Announces Receipt of Notices From Bank Leumi - Update

May 21, 2013
·
2 min read
Mindray Medical Announces Its Recent Filing of Annual Report on Form 20-F With the U.S. Securities and Exchange Commission

May 21, 2013
·
1 min read
Drug Development

Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients With Schizophrenia Compared to Seroquel XR® (quetiapine XR)

May 21, 2013
·
1 min read
BioCapital

BioElectronics Corporation Presents FDA Reclassification Panel

May 21, 2013
·
3 min read
Business

IsoRay Announces a New International Distributor for Greece

May 21, 2013
·
4 min read
Genetown

Boston Scientific Corporation Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients With Severe Asthma

May 21, 2013
·
7 min read
Business

ALung Technologies to Pursue SFDA Approval of Hemolung RAS in China

May 21, 2013
·
1 min read